Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 30, Issue 2, 2012, Pages 172-178

  Scagliotti, Giorgio V ^a   Pastorino, Ugo ^b   Vansteenkiste, Johan F ^g   Spaggiari, Lorenzo ^c   Facciolo, Francesco ^e   Orlowski, Tadeusz M ^h   Maiorino, Luigi ^f   Hetzel, Martin ⁱ   Leschinger, Monika ^j   Visseren Grul, Carla ^k   Torri, Valter ^d  

^a UNIVERSITY OF TURIN   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^f San Gennaro Hospital   (Italy)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h Institute of Chest Disease   (Poland)

ⁱ Red Cross Hospital   (Germany)

^j LILLY DEUTSCHLAND GMBH   (Germany)

^k Eli Lilly Oncology ^*  (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; BRONCHUS FISTULA; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; LEUKOPENIA; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SURGICAL MORTALITY; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING;

EID: 84855616346     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.33.7089     Document Type: Article

References (34)

1. Ferlay J, Autier P, Boniol M, et al: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581-592, 2007 (Pubitemid 46359643)
2. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2009. CA Cancer J Clin 59:225-249, 2009
3. Shepherd FA: Screening, diagnosis, and staging of lung cancer. Curr Opin Oncol 5:310-322, 1993
4. Walling J: Chemotherapy for advanced non-small-cell lung cancer. Respir Med 88:649-657, 1994
5. Gloeckler Ries LA, Reichman ME, Lewis DR, et al: Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist 8:541-552, 2003 (Pubitemid 37467370)
6. Berghmans T, Paesmans M, Meert AP, et al: Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature. Lung Cancer 49:13-23, 2005 (Pubitemid 40798089)
7. Burdett S, Stewart LA, Rydzewska L: A systematic review and meta-analysis of the literature: Chemotherapy and surgery versus surgery alone in non-small cell lung cancer. J Thorac Oncol 1:611-621, 2006 (Pubitemid 47163946)
8. Ahrendt SA, Yang SC, Wu L, et al: Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: Preliminary results of a prospective study. J Thorac Cardiovasc Surg 123:466-473, 2002; discussion 473-474
9. D'Cunha J, Corfits AL, Herndon JE 2nd, et al: Molecular staging of lung cancer: Real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I nonsmall cell lung cancer - Preliminary results of Cancer and Leukemia Group B Trial 9761. J Thorac Cardiovasc Surg 123:484-491, 2002; discussion 491
10. Pantel K, Izbicki JR, Angstwurm M, et al: Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 53:1027-1031, 1993 (Pubitemid 23087902)
11. Passlick B, Kubuschok B, Izbicki JR, et al: Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer. Ann Thorac Surg 68:2053-2058, 1999 (Pubitemid 30027824)
12. Scagliotti GV, Fossati R, Torri V, et al: Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer. J Natl Cancer Inst 95:1453-1461, 2003 (Pubitemid 37279330)
13. Arriagada R, Bergman B, Dunant A, et al: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350:351-360, 2004 (Pubitemid 38101630)
14. Douillard JY, Rosell R, De Lena M, et al: Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial. Lancet Oncol 7:719-727, 2006 (Pubitemid 44283661)
15. Strauss GM, Herndon JE 2nd, Maddaus MA, et al: Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 26:5043-5051, 2008
16. Betticher D, Schmitz S, Gauthier Y, et al: Neoadjuvant chemotherapy with docetaxel (DOC, Taxotere) and cisplatin (CIS) in patients (pts) with non-small cell lung cancer (NSCLC), stage IIIA, N2 is highly active with few toxicities. Proc Am Soc Clin Oncol 18:491a, 1999 (abstr 1824)
17. Cigolari S, Curcio C, Maiorino A, et al: Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer: Final results of a multicenter phase II study. Anticancer Res 23:1803-1809, 2003 (Pubitemid 36750852)
18. Pisters KM, Ginsberg RJ, Putman JB, et al: Induction paclitaxel and carboplatin (PC) in early stage non-small cell lung cancer (NSCLC): Early results of a completed phase II trial. Proc Am Soc Clin Oncol 18:467a, 1999 (abstr 1800)
19. Van Zandwijk N, Smit EF, Kramer GW, et al: Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). J Clin Oncol 18:2658-2664, 2000 (Pubitemid 30463547)
20. Rosell R, Gómez-Codina J, Camps C, et al: Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: A 7-year assessment of a randomized controlled trial. Lung Cancer 26:7-14, 1999 (Pubitemid 29469711)
21. Roth JA, Fossella F, Komaki R, et al: A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 86:673-680, 1994
22. Depierre A, Milleron B, Moro-Sibilot D, et al: Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 20:247-253, 2002 (Pubitemid 34032618)
23. Fleming ID, Cooper JS, Henson DE, et al (eds): American Joint Committee on Cancer Staging Manual (ed 5). Philadelphia, PA, Lippincott-Raven, 1998
24. Cancer Therapy Evaluation Program: National Cancer Institute-Common Toxicity Criteria, Version 2.0, 1999
25. Strauss GM, Herndon J, Maddaus MA, et al: Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. J Clin Oncol 22:621s, 2004 (suppl; abstr 7019)
26. Winton TL, Livingston R, Johnson D, et al: A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage IB and II non small cell lung cancer (NSCLC) Intergroup JBR.10. J Clin Oncol 22:621s, 2004 (suppl; abstr 7018)
27. Pisters KM, Vallière E, Crowley JJ, et al: Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. J Clin Oncol 28:1843-1849, 2010
28. Gilligan D, Nicolson M, Smith I, et al: Preoperative chemotherapy in patients with resectable non-small cell lung cancer: Results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review. Lancet 369:1929-1937, 2007 (Pubitemid 46874559)
29. Felip E, Rosell R, Maestre JA, et al: Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer. J Clin Oncol 28:3138-3145, 2010
30. Pignon JP, Tribodet H, Scagliotti GV, et al: Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE Collaborative Group. J Clin Oncol 26:3552-3559, 2008
31. Pisters K, Vallieres E, Bunn PA, et al: S9900: Surgery alone or surgery plus induction (ind) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Follow-up on a phase III trial. J Clin Oncol 25:520s, 2007 (suppl: abstr 7520)
32. Pass HI, Pogrebniak HW, Steinberg SM, et al: Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis. Ann Thorac Surg 53:992-998, 1992
33. Roth JA, Atkinson EN, Fossella F, et al: Longterm follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 21:1-6, 1998 (Pubitemid 29027851)
34. Robinson LA, Ruckdeschel JC, Wagner H Jr, et al: Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:243S-265S, 2007 (suppl 3)